Filing Details

Accession Number:
0001144204-12-050783
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-12 10:26:40
Reporting Period:
2012-09-11
Filing Date:
2012-09-12
Accepted Time:
2012-09-12 10:26:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1323854 Warner Chilcott Plc WCRX Pharmaceutical Preparations (2834) 980626948
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1347024 P Stephen Murray C/O Ccmp Capital Advisors, Llc
245 Park Avenue
New York NY 10167
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2012-09-11 14,000,000 $13.10 11,491,618 No 4 S Indirect See Foonotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Foonotes
Footnotes
  1. The amounts shown represent the beneficial ownership of the Issuer's securities by (i) J.P. Morgan Partners (BHCA), L.P. ("JPMP BHCA"), (ii) J.P. Morgan Partners Global Investors, L.P. ("J.P.Morgan Global"), (iii) J.P. Morgan Partners Global Investors A, L.P. (" JPMP Global A"), (iv) J.P. Morgan Partners Global Investors (Cayman), L.P. ("JPMP Cayman"), (v) J.P. Morgan Partners Global Investors (Cayman) II, L.P. ("JPMP Cayman II"), (vi) J.P. Morgan Partners Global Investors (Cayman) III, L.P. ("JPMP Cayman III"), (vii) J.P. Morgan Partners Global Investors (Selldown), L.P. ("JPMP Selldown"), (viii) J.P. Morgan Partners Global Investors (Selldown) II-A, L.P. ("JPMP Selldown II-A"), (ix) J.P. Morgan Partners Global Investors (Cayman /Selldown) III, L.P. ("JPMP Selldown III", and together with J.P. Morgan Global, JPMP Global A, JPMP Cayman, JPMP Cayman II, JPMP Cayman III, JPMP Selldown, JPMP Selldown II-A, the "Global Funds"). (continued in footnote 2)
  2. (continued from footnote 1) The Reporting Person is a limited partner of JPMP Master Fund Manager, L.P. ("JPMP MFM"). JPMP MFM is the general partner of JPMP BHCA and a limited partner of JPMP Global Investors, L.P. ("JPMP Global Investors"), the general partner of the Global Funds. The actual pro rata portion of such beneficial ownership that may be deemed attributable to the Reporting Person is not readily determinable because it is subject to several variables, including the internal rate of return and vesting of interests within JPMP BHCA, JPMP MFM, JPMP Global Investors and the Global Funds. Mr. Murray disclaims beneficial ownership of the securities to the extent it exceeds his pecuniary interest therein.